Broiler E. coli Infection: Diagnosis and Management

At a Glance

Avian pathogenic Escherichia coli (APEC) causes colibacillosis in broiler flocks, presenting as airsacculitis, pericarditis, and perihepatitis. This syndrome-level investigation covers diagnostic methods, antimicrobial therapy considerations, and prevention through management and vaccination. The table below summarizes key clinical presentations and initial diagnostic approaches.

Syndrome Recognition and Clinical Presentation

Colibacillosis in broiler flocks typically emerges as a secondary infection following respiratory viral diseases or environmental stress. The World Organisation for Animal Health recognizes APEC as a significant cause of economic loss in poultry production worldwide. Clinical signs include depression, reduced feed intake, huddling, and respiratory distress. Mortality often increases over 3 to 7 days, with peak losses occurring in birds aged 2 to 6 weeks.

The characteristic postmortem lesions involve fibrinous inflammation of serosal surfaces. Airsacculitis appears as thickened, cloudy air sacs with yellow fibrinous exudate. Pericarditis presents as a thickened, opaque pericardium with fibrin accumulation. Perihepatitis shows a fibrinous coating on the liver surface, often described as a glazed appearance. These three lesions frequently occur together and form the classic colibacillosis triad.

Respiratory signs develop when APEC colonizes the lower respiratory tract following damage to the respiratory epithelium. Birds may show open-mouth breathing, tracheal rales, and increased respiratory effort. Affected flocks often have uneven growth rates and increased culling of sick birds. The incubation period from exposure to clinical signs ranges from 24 to 72 hours under field conditions.

Acute septicemic presentations cause sudden death with minimal premonitory signs. These cases occur most frequently in young broilers during the second and third weeks of life. Postmortem examination reveals generalized congestion, enlarged liver and spleen, and petechial hemorrhages on serosal surfaces. Fibrinous lesions may be absent in peracute cases.

Chronic infections manifest as poor growth, lameness from arthritis, and reduced uniformity within the flock. Layers and breeders may develop salpingitis with egg peritonitis. These chronic presentations result from localized infection following bacteremic spread. The economic impact includes increased mortality, reduced feed conversion, and higher treatment costs.

Diagnostic Methods

Bacterial Culture and Isolation

Isolation of E. coli from affected tissues confirms the diagnosis. Collect samples from liver, spleen, air sacs, and pericardial sac using sterile technique. Transport samples in appropriate media to a diagnostic laboratory. The Merck Veterinary Manual provides standard protocols for avian bacterial culture. Culture on MacConkey agar reveals lactose-fermenting colonies typical of E. coli. Further biochemical testing or commercial identification systems confirm the species.

Select fresh, untreated birds for postmortem examination. Birds that have received antimicrobial therapy within 48 hours may yield false-negative culture results. Submit multiple birds representing different stages of disease. Include samples from affected tissues and from birds without gross lesions for comparison. Contact the laboratory for specific submission requirements and transport instructions.

Quantitative culture of air sac or pericardial swabs can help differentiate infection from contamination. Heavy growth of E. coli in pure culture from multiple tissues supports a diagnosis of colibacillosis. Mixed growth with other bacteria may indicate secondary contamination or concurrent infection. The laboratory report should include the relative abundance of each organism isolated.

Serotyping and Molecular Characterization

Serotyping identifies the O antigen type, with O78, O2, and O1 being common APEC serotypes in broilers. Molecular methods detect virulence genes associated with APEC pathotypes. A 2022 study published in Veterinary Microbiology demonstrated high sequence similarity between APEC isolates from individual birds and within broiler chicken flocks during colibacillosis outbreaks. This finding supports the clonal spread of pathogenic strains within affected flocks.

Polymerase chain reaction (PCR) assays target virulence genes such as iss, iroN, ompT, hlyF, and fimC. These genes encode factors for iron acquisition, serum resistance, and adhesion. Detection of multiple virulence genes strengthens the diagnosis of APEC versus commensal E. coli. A 2025 study from Indonesia published in the Archives of Razi Institute described histopathological diagnosis combined with virulence gene detection in broiler chickens.

Molecular typing methods such as pulsed-field gel electrophoresis (PFGE) or multilocus sequence typing (MLST) can track strain transmission within and between flocks. These methods help identify sources of infection and evaluate the effectiveness of biosecurity measures. The 2017 study in Veterinary Microbiology on dynamics of CMY-2 producing E. coli in a broiler parent flock demonstrated how molecular typing reveals strain persistence and spread.

Antimicrobial Susceptibility Testing

Perform antimicrobial susceptibility testing on isolates from clinical cases to guide therapy. Disk diffusion or broth microdilution methods provide minimum inhibitory concentration (MIC) data. The emergence of antimicrobial resistance in APEC strains requires routine monitoring. A 2023 study in the International Journal of Food Microbiology reported the molecular characteristics of mcr-1 colistin-resistant E. coli isolated from retail broiler meat in Bangladesh, highlighting the public health concern of resistance gene transfer.

A 2025 study from Uganda published in PLOS ONE examined the prevalence and antimicrobial resistance of pathogenic E. coli in broiler farms. Results from such studies inform regional resistance patterns and treatment decisions. Request susceptibility testing for commonly used antimicrobial classes including aminoglycosides, fluoroquinolones, tetracyclines, and beta-lactams.

Interpret susceptibility results using clinical breakpoints established for avian isolates when available. Human breakpoints may not accurately predict therapeutic response in poultry. Discuss interpretation of results with the diagnostic laboratory and your veterinary advisor. Maintain a farm-specific antibiogram that tracks resistance trends over time.

Histopathology

Histological examination of affected tissues confirms the fibrinous inflammatory response. Sections of liver, heart, and air sacs show fibrin deposition, heterophil infiltration, and bacterial colonies. Gram staining reveals gram-negative rods within lesions. Histopathology helps differentiate colibacillosis from other causes of polyserositis such as mycoplasmosis or pasteurellosis.

The histopathological features of acute colibacillosis include heterophilic inflammation with fibrin exudation. Chronic lesions show macrophage infiltration, fibrosis, and granulation tissue formation. Bacterial emboli may be visible in blood vessels of affected organs. The presence of gram-negative rods within fibrin deposits supports the diagnosis.

Histopathology is particularly useful when bacterial culture results are negative due to prior antimicrobial therapy. The characteristic tissue response confirms colibacillosis even when organisms are not viable. Immunohistochemistry using antibodies against E. coli antigens can detect bacterial components in formalin-fixed tissues.

Antimicrobial Therapy

Principles of Antimicrobial Selection

Select antimicrobials based on culture and susceptibility results from the affected flock. Empirical therapy may be necessary while awaiting laboratory results, guided by local resistance patterns and previous farm history. The World Organisation for Animal Health provides standards for prudent antimicrobial use in animal agriculture. Avoid using antimicrobials classified as critically important for human medicine when alternatives exist.

Common antimicrobial classes used in broiler colibacillosis include amoxicillin, potentiated sulfonamides, tetracyclines, fluoroquinolones, and aminoglycosides. Each class has specific indications, withdrawal periods, and regulatory approvals that vary by country. Consult local veterinary regulations and product labels for approved uses and withdrawal times.

Consider the pharmacokinetics of each antimicrobial class when selecting treatment. Drugs with good tissue penetration and activity against intracellular bacteria are preferred for systemic infections. Beta-lactam antibiotics achieve therapeutic concentrations in respiratory tissues. Fluoroquinolones concentrate in macrophages and reach high levels in inflamed tissues.

Treatment Administration Routes

Water medication is the most practical route for broiler flocks. Calculate the daily water intake based on flock age, body weight, and environmental temperature. Ensure adequate mixing and stability of the antimicrobial in the water system. In severe outbreaks with reduced water intake, individual bird injection may be necessary for valuable breeders or small flocks.

Medication through feed is an alternative for flocks with adequate feed intake. This route provides more consistent dosing than water medication but requires longer mixing time. Feed medication is less suitable for acutely ill birds that have reduced feed consumption. Consult with a feed mill or nutritionist to ensure uniform distribution of the antimicrobial in the feed.

Duration of treatment typically ranges from 3 to 5 days, depending on the antimicrobial used and clinical response. Monitor mortality and clinical signs daily during treatment. If no improvement occurs within 48 hours, reassess the diagnosis and susceptibility results. Complete the full course as prescribed to prevent relapse and resistance development.

Antimicrobial Resistance Considerations

Resistance to multiple antimicrobial classes is common in APEC isolates. A 2017 study in Veterinary Microbiology described the dynamics of CMY-2 producing E. coli in a broiler parent flock, demonstrating how beta-lactamase genes can spread within and between flocks. This underscores the importance of susceptibility testing before treatment.

Colistin resistance mediated by the mcr-1 gene has been detected in poultry isolates globally. The 2023 report from Bangladesh in the International Journal of Food Microbiology confirms this resistance mechanism in retail broiler meat. Avoid using colistin as a first-line treatment for colibacillosis due to its critical importance in human medicine and the risk of resistance dissemination.

Extended-spectrum beta-lactamase (ESBL) producing E. coli are increasingly reported in poultry. These strains are resistant to most beta-lactam antibiotics including third-generation cephalosporins. Fluoroquinolone resistance is also widespread in many regions. Regular susceptibility testing is essential to identify effective treatment options.

Prevention Through Management

Biosecurity Measures

Implement strict biosecurity protocols to prevent APEC introduction and spread. Use dedicated footwear and clothing for each house. Maintain footbaths with effective disinfectants at house entrances. Control visitor access and implement downtime periods between flocks. The Animal Health and Welfare division of the World Organisation for Animal Health provides guidelines for biosecurity in poultry production.

Rodent and insect control reduces the risk of mechanical transmission of E. coli between houses. Clean and disinfect water lines between flocks to remove biofilm that can harbor bacteria. Monitor water quality regularly, as contaminated drinking water is a common source of E. coli infection.

All-in-all-out management prevents carryover of infection between age groups. Clean and disinfect houses thoroughly between flocks, including feed bins, water lines, and ventilation equipment. Allow adequate downtime of at least 14 days between flocks to break infection cycles. Test environmental samples after cleaning to verify disinfection effectiveness.

Environmental Management

Optimize ventilation to reduce ammonia levels and respiratory irritation. High ammonia concentrations damage the respiratory epithelium, predisposing birds to secondary E. coli infection. Maintain litter quality to prevent wet conditions that favor bacterial growth. Adjust stocking density according to house capacity and ventilation capability.

Temperature and humidity control during brooding supports immune system development. Chilling or overheating during the first week of life increases susceptibility to colibacillosis. Provide adequate feeder and drinker space to reduce competition and stress.

Litter management directly affects E. coli levels in the house. Caked or wet litter supports bacterial proliferation and increases exposure. Add litter amendments to control moisture and ammonia when needed. Remove wet litter promptly and maintain proper ventilation to keep litter dry.

Stress Reduction

Minimize stressors that compromise immune function. Vaccination programs should be timed to avoid overlap with periods of environmental stress. Handle birds gently during catching and transport. Provide adequate nutrition, particularly vitamins A, C, and E, which support immune function.

A 2020 study in Tropical Animal Health and Production examined the impact of dietary supplementation with Echinacea purpurea on growth performance and immunological findings in broiler chickens infected by pathogenic E. coli. While specific results are not detailed here, such research indicates ongoing investigation into nutritional strategies for disease mitigation.

Water quality affects gut health and immune function. Test water sources for bacterial contamination, pH, and mineral content. Chlorinate drinking water to reduce bacterial load. Clean water lines between flocks to remove biofilm that can harbor E. coli.

Vaccination Strategies

Autogenous Vaccines

Autogenous (farm-specific) vaccines can be developed from APEC isolates recovered from affected flocks. A diagnostic laboratory isolates the predominant serotype and produces a killed bacterin or subunit vaccine. These vaccines provide serotype-specific protection and are most useful when a single APEC serotype predominates on a farm.

Administer autogenous vaccines to parent flocks to provide maternal antibody transfer to progeny. Vaccination of broilers directly may be considered in high-risk situations, though the short lifespan limits the window for immune response development. Consult with a poultry veterinarian to determine if autogenous vaccination is appropriate for your operation.

The process of developing an autogenous vaccine requires submission of representative isolates from affected flocks. The laboratory confirms the serotype and virulence gene profile of the isolates. Production and quality control take several weeks. Plan ahead to have vaccine available before the next high-risk period.

Commercial Vaccines

Several commercial E. coli vaccines are available in different regions. These products typically contain inactivated whole cells or purified antigens from common APEC serotypes. Vaccination protocols vary by product and target population. Some vaccines are licensed for use in breeders to provide passive immunity to progeny, while others are approved for direct vaccination of broilers.

Efficacy of commercial vaccines depends on the match between vaccine serotypes and field strains. Cross-protection between serotypes is limited, so vaccine selection should be based on the serotypes circulating in your region. Discuss vaccine options with your veterinary advisor and review local efficacy data.

Live attenuated vaccines are available in some markets. These vaccines stimulate both humoral and cell-mediated immunity. They are typically administered by spray or drinking water to day-old chicks. Live vaccines carry a low risk of reversion to virulence and should be used according to manufacturer instructions.

Vaccine Program Design

Design vaccination programs based on farm-specific risk factors and serotype prevalence. Breeder vaccination provides maternal antibody protection during the first two weeks of life. Broiler vaccination can boost immunity in high-risk flocks. Combine vaccination with management improvements for optimal control.

Monitor vaccine efficacy by tracking colibacillosis incidence before and after program implementation. Compare mortality rates, treatment frequency, and lesion scores between vaccinated and unvaccinated flocks. Adjust the program based on field results and changes in serotype prevalence.

Records and Measurements

Flock Monitoring Records

Maintain daily records of mortality, feed intake, water consumption, and clinical signs. Calculate weekly mortality rates and compare to target values for the flock age. Record any treatments administered, including product name, dose, duration, and withdrawal period. Document environmental parameters such as temperature, humidity, and ammonia levels.

When colibacillosis is suspected, record the age at onset, duration of clinical signs, and cumulative mortality. Note any preceding respiratory disease or stress events. These records help identify predisposing factors and guide prevention strategies for subsequent flocks.

Use standardized forms for daily flock monitoring to ensure consistent data collection. Train staff to recognize and record early signs of disease. Review records regularly to identify trends that may indicate emerging problems.

Diagnostic Records

Document all laboratory submissions including sample type, date, and results. Record bacterial culture results, serotype identification, and antimicrobial susceptibility patterns. Maintain a farm-specific antibiogram that tracks resistance trends over time. Share diagnostic findings with your veterinary advisor to inform treatment protocols.

Keep records of postmortem examination findings, including the distribution and severity of lesions. Photograph representative lesions for training and reference purposes. These records support accurate diagnosis and help differentiate colibacillosis from other causes of mortality.

Create a database of farm-specific diagnostic results to track changes over time. Note seasonal patterns, age predilections, and serotype shifts. Use this information to predict high-risk periods and adjust prevention strategies accordingly.

Treatment Outcome Records

Record the response to antimicrobial therapy, including changes in mortality and clinical signs. Note any adverse reactions or treatment failures. Document the duration of treatment and the withdrawal period observed. Compare treatment outcomes with susceptibility results to validate laboratory findings.

Track antimicrobial use by class and quantity to monitor usage patterns. This information supports antimicrobial stewardship efforts and compliance with regulatory requirements. Review treatment records with your veterinarian to identify opportunities for improvement.

Calculate treatment cost per bird and compare to the economic benefit of reduced mortality and improved performance. Use this data to make informed decisions about treatment protocols and prevention investments.

Common Failure Patterns

Incomplete Diagnosis

Failure to perform bacterial culture and susceptibility testing leads to inappropriate antimicrobial selection. Treating based on clinical signs alone risks using ineffective drugs and contributing to resistance development. Always submit samples for laboratory confirmation, especially when outbreaks occur in previously unaffected flocks.

Misdiagnosis of colibacillosis can occur when other causes of polyserositis are present. Mycoplasma gallisepticum, Pasteurella multocida, and Ornithobacterium rhinotracheale can produce similar lesions. Laboratory testing is essential to differentiate these pathogens and guide appropriate treatment.

Relying on a single bird for diagnosis may miss flock-level patterns. Submit multiple birds representing different stages of disease. Include birds with acute lesions and those with chronic changes. Compare findings across birds to identify the predominant disease process.

Inadequate Biosecurity

Lapses in biosecurity allow APEC introduction and spread between houses. Shared equipment, personnel movement, and inadequate cleaning between flocks perpetuate infection cycles. Review biosecurity protocols regularly and audit compliance. Address any gaps identified during outbreak investigations.

Failure to control predisposing factors such as respiratory viruses, mycoplasma, or environmental stress reduces the effectiveness of treatment and prevention efforts. Colibacillosis is often a secondary infection, so controlling primary causes is essential for long-term control.

Water line biofilm is a common reservoir for E. coli that is often overlooked. Regular cleaning and disinfection of water lines between flocks reduces bacterial load. Monitor water quality at multiple points in the system to identify contamination sources.

Antimicrobial Misuse

Using subtherapeutic doses or inadequate treatment duration promotes resistance development. Stopping treatment prematurely when clinical signs improve may allow relapse. Always complete the full course of treatment as prescribed by your veterinarian.

Reusing the same antimicrobial class repeatedly without susceptibility testing selects for resistant strains. Rotate antimicrobial classes based on susceptibility results and veterinary guidance. Avoid using antimicrobials classified as critically important for human medicine when suitable alternatives exist.

Treating flocks with low mortality or mild clinical signs may not be economically justified. Consider the cost of treatment versus the expected benefit. Consult with your veterinarian to establish treatment thresholds based on farm-specific factors.

Welfare and Safety Context

Bird Welfare Considerations

Colibacillosis causes significant pain and distress in affected birds. Fibrinous inflammation of serosal surfaces impairs respiratory and cardiac function. Birds with severe lesions experience dyspnea, lethargy, and reduced mobility. Prompt diagnosis and treatment are essential to minimize suffering.

Cull birds with severe clinical signs that are unlikely to respond to treatment. Humane euthanasia methods approved by the World Organisation for Animal Health should be used. Birds that cannot access feed or water due to illness should be euthanized promptly.

Monitor welfare indicators such as activity level, feeding behavior, and respiratory effort. Birds that are unable to stand or reach feed and water require immediate attention. Implement treatment protocols that prioritize bird welfare while considering economic factors.

Food Safety Implications

APEC strains can carry antimicrobial resistance genes that pose a public health risk. The detection of mcr-1 colistin resistance in retail broiler meat highlights the potential for resistance transfer through the food chain. Proper cooking and handling of poultry meat reduce the risk of foodborne transmission.

Observe withdrawal periods for all antimicrobials used in broiler flocks. Residue testing programs monitor compliance with withdrawal requirements. Violations can result in regulatory action and loss of market access. Maintain accurate treatment records to ensure withdrawal periods are observed.

The World Organisation for Animal Health provides standards for antimicrobial use in food-producing animals. Follow these standards to minimize the risk of resistance development and ensure food safety. Participate in antimicrobial stewardship programs to demonstrate responsible use.

Occupational Safety

Farm personnel handling sick birds or performing postmortem examinations should use appropriate personal protective equipment. E. coli can cause opportunistic infections in humans, particularly in immunocompromised individuals. Hand washing after bird contact and before eating is essential.

Needle stick injuries during vaccination or treatment administration require immediate first aid and medical evaluation. Use needle disposal containers and follow safe injection practices. Train staff on proper handling and disposal of sharps.

Respiratory protection may be needed when working in dusty or high-ammonia environments. Provide training on proper use of respirators and ensure fit testing. Monitor air quality in poultry houses to identify hazards.

Professional Escalation Criteria

Urgent Veterinary Consultation

Contact a veterinarian immediately if any of the following occur:

• Mortality exceeds 1 percent per day for two consecutive days
• Clinical signs suggestive of a notifiable disease such as avian influenza or Newcastle disease
• Suspected antimicrobial treatment failure with no improvement after 48 hours
• Unusual clinical presentation not consistent with typical colibacillosis
• Involvement of multiple houses simultaneously with rapid spread

Urgent consultation is also indicated when respiratory signs are severe or when birds show neurological signs. These presentations may indicate highly pathogenic avian influenza or other reportable diseases. The World Organisation for Animal Health provides guidance on notifiable disease reporting.

Routine Veterinary Consultation

Schedule a veterinary visit for the following situations:

• Review of diagnostic results and treatment protocols
• Development of a farm-specific vaccination program
• Investigation of recurrent colibacillosis outbreaks
• Audit of biosecurity practices and identification of improvement areas
• Review of antimicrobial usage patterns and stewardship goals

Routine consultations should occur at least quarterly for farms with recurrent colibacillosis. More frequent visits may be needed during high-risk periods such as seasonal transitions. Use these visits to review records and adjust prevention strategies.

Laboratory Submission Guidelines

Submit samples to a diagnostic laboratory when:

• First occurrence of colibacillosis on the farm
• Change in clinical presentation or lesion pattern
• Suspected antimicrobial resistance
• Need for serotype identification for vaccine development
• Regulatory requirement for disease investigation

Select fresh, untreated birds for postmortem examination. Submit multiple birds representing different stages of disease. Include samples from affected tissues and from birds without gross lesions for comparison. Contact the laboratory for specific submission requirements and transport instructions.

Decision Framework for Antimicrobial Selection in Broiler Colibacillosis

Selecting an antimicrobial for a colibacillosis outbreak requires a structured approach that balances treatment efficacy, resistance risk, regulatory compliance, and economic considerations. A practical decision framework helps farm managers and veterinarians make consistent, evidence-informed choices instead of relying on habit or convenience. This framework integrates diagnostic data, farm history, and treatment response monitoring into a repeatable process.

Step 1: Confirm the Diagnosis Before Treatment

Begin treatment only after collecting appropriate diagnostic samples. Submit liver, spleen, air sac swabs, and pericardial swabs from three to five affected birds for bacterial culture and antimicrobial susceptibility testing. The Merck Veterinary Manual recommends collecting samples from freshly dead or euthanized birds that have not received antimicrobial therapy within the previous 48 hours. If mortality is rising rapidly and empirical treatment must begin immediately, collect samples first and then start therapy while awaiting laboratory results.

Record the following information at the time of sample collection: flock age, daily mortality rate for the preceding three days, clinical signs observed, any treatments administered in the previous week, and environmental conditions including ammonia levels and ventilation status. This baseline data supports later evaluation of treatment response.

Step 2: Review Farm-Specific Resistance Patterns

Maintain a farm-specific antibiogram that summarizes susceptibility results from the most recent 10 to 20 E. coli isolates recovered from your flocks. Update this antibiogram at least annually or after every outbreak. The antibiogram should list the percentage of isolates susceptible to each antimicrobial class tested. Use this information to identify first-line and second-line treatment options before reviewing results from the current outbreak.

If no farm-specific antibiogram exists, consult regional resistance data from diagnostic laboratories or published studies. A 2025 study in PLOS ONE examining broiler farms in Uganda reported prevalence and antimicrobial resistance patterns of pathogenic E. coli in that region. While specific resistance percentages vary by location, such studies highlight the importance of local data for treatment decisions.

Step 3: Select Antimicrobial Class Based on Susceptibility and Regulatory Status

When susceptibility results are available, select an antimicrobial to which the isolate is susceptible. When results are pending and empirical treatment is necessary, choose an antimicrobial class that has shown greater than 80 percent susceptibility in your farm's recent antibiogram or regional data. Avoid antimicrobials classified as critically important for human medicine by the World Organisation for Animal Health when suitable alternatives exist.

Common antimicrobial classes used in broiler colibacillosis include:

• Amoxicillin: Effective against susceptible isolates, good respiratory tissue penetration, short withdrawal period
• Potentiated sulfonamides (trimethoprim-sulfamethoxazole): Broad spectrum, available in water-soluble formulations, variable resistance in some regions
• Tetracyclines (oxytetracycline, doxycycline): Economical, but resistance is widespread in many areas
• Fluoroquinolones (enrofloxacin): Highly effective against susceptible isolates, but classified as critically important for human medicine, reserve for cases where no alternative exists
• Aminoglycosides (gentamicin, spectinomycin): Used primarily for injectable treatment in individual birds or small flocks

Consider the pharmacokinetic properties of each class. Beta-lactam antibiotics such as amoxicillin achieve therapeutic concentrations in respiratory tissues and are effective against extracellular bacteria. Fluoroquinolones concentrate in macrophages and reach high levels in inflamed tissues, making them useful for intracellular infections. The World Organisation for Animal Health provides standards for prudent antimicrobial use that include considering pharmacokinetics when selecting treatment.

Step 4: Determine Administration Route and Dose

Water medication is the most practical route for broiler flocks. Calculate the daily water intake based on flock age, body weight, and environmental temperature. Use the following formula as a starting point: daily water intake in liters equals 1.5 to 2.0 times the daily feed intake in kilograms, adjusted for temperature. At high temperatures, water intake may increase by 50 percent or more.

Ensure the antimicrobial is fully soluble in water and stable for the duration of the medication period. Mix the calculated dose in a stock solution and add it to the water system using a proportioner or medicator. Verify that the medicator is calibrated correctly before starting treatment. Flush water lines after the medication period to remove residual antimicrobial.

For flocks with severely reduced water intake, individual bird injection may be necessary. This route is practical only for small flocks or valuable breeders. Administer injections in the breast muscle or subcutaneous tissue of the neck, rotating injection sites to reduce tissue damage. Use sterile needles and change needles frequently to prevent abscess formation.

Step 5: Monitor Treatment Response Daily

Record mortality, feed intake, water consumption, and clinical signs each day during treatment. Calculate the daily mortality rate as a percentage of the flock population. Compare this rate to the pretreatment baseline. A positive response typically shows a reduction in mortality within 24 to 48 hours of starting effective therapy.

Use a standardized treatment response form that includes the following fields:

• Date and time of treatment start
• Antimicrobial product name and batch number
• Dose rate and administration route
• Daily mortality count and percentage
• Number of birds showing clinical signs (depression, respiratory distress, huddling)
• Feed and water intake estimates
• Any adverse reactions observed
• Staff observations on bird activity and behavior

If mortality does not decrease within 48 hours, or if it continues to rise, reassess the diagnosis. Contact your veterinarian to review the case. Consider the possibility of antimicrobial resistance, incorrect diagnosis, or concurrent infection. Request preliminary susceptibility results from the laboratory if they are not yet available.

Step 6: Evaluate Treatment Outcome and Adjust Future Protocols

After completing the treatment course, compare the total mortality and treatment cost to the expected outcome based on farm history. Calculate the treatment cost per bird by dividing the total cost of antimicrobial and administration by the number of birds treated. Compare this to the value of birds saved, estimated as the difference between expected mortality without treatment and actual mortality with treatment.

Record the treatment outcome in the farm records, including the antimicrobial used, dose, duration, and response. Note any factors that may have influenced the outcome, such as concurrent disease, environmental stress, or management changes. Use this information to refine treatment protocols for future outbreaks.

If the same antimicrobial class has been used for three or more consecutive outbreaks, consider rotating to a different class to reduce selection pressure for resistance. Discuss rotation protocols with your veterinarian based on susceptibility trends.

Common Decision Errors and How to Avoid Them

Error 1: Treating without collecting diagnostic samples. This prevents confirmation of the diagnosis and eliminates the opportunity for susceptibility testing. Always collect samples before starting treatment, even if empirical therapy begins immediately.

Error 2: Using the same antimicrobial repeatedly without susceptibility testing. This selects for resistant strains and reduces future treatment options. Rotate antimicrobial classes based on susceptibility results, not convenience.

Error 3: Stopping treatment prematurely when clinical signs improve. Incomplete treatment courses allow surviving bacteria to repopulate and may select for resistance. Complete the full course as prescribed by your veterinarian.

Error 4: Ignoring predisposing factors. Treating colibacillosis without addressing underlying respiratory disease, poor ventilation, or high ammonia levels leads to recurrent outbreaks. Management improvements are essential for long-term control.

Error 5: Using antimicrobials classified as critically important for human medicine when alternatives exist. This practice contributes to antimicrobial resistance in both animal and human pathogens. Reserve fluoroquinolones and third-generation cephalosporins for cases where no effective alternative is available.

Integrating the Framework into Farm Protocols

Print the decision framework as a flowchart and post it in the farm office or treatment room. Train all staff involved in disease detection and treatment on the steps. Review the framework with your veterinarian during routine consultations and update it as new susceptibility data becomes available.

Use the framework in conjunction with the farm-specific antibiogram and treatment outcome records. Over time, this systematic approach will improve treatment success rates, reduce antimicrobial use, and support antimicrobial stewardship goals. The World Organisation for Animal Health provides additional guidance on prudent antimicrobial use in animal agriculture that can be incorporated into farm protocols.

When to Escalate Beyond the Framework

The decision framework applies to typical colibacillosis outbreaks where the diagnosis is confirmed and susceptibility results are available. Escalate to urgent veterinary consultation when any of the following occur:

• Mortality exceeds 1 percent per day for two consecutive days despite treatment
• No improvement in clinical signs within 48 hours of starting treatment
• Suspected notifiable disease such as avian influenza or Newcastle disease
• Unusual clinical presentation not consistent with typical colibacillosis
• Involvement of multiple houses simultaneously with rapid spread

In these situations, the framework alone is insufficient. Contact your veterinarian immediately for case review and additional diagnostic testing. The World Organisation for Animal Health provides guidance on notifiable disease reporting that should be followed when reportable diseases are suspected.

Frequently Asked Questions

What are the most common postmortem lesions of colibacillosis in broilers?

The classic triad includes airsacculitis (thickened, cloudy air sacs with fibrin), pericarditis (fibrinous inflammation of the heart sac), and perihepatitis (fibrinous coating on the liver surface). These lesions result from the systemic inflammatory response to APEC infection and are typically seen together in affected birds. Acute septicemic cases may show only congestion and enlarged organs without fibrinous lesions.

How is avian pathogenic E. coli different from commensal E. coli?

APEC strains possess specific virulence genes that enable them to cause disease. These genes encode factors for adhesion, iron acquisition, serum resistance, and toxin production. Commensal E. coli lack these virulence determinants and do not cause systemic infection in healthy birds. Molecular testing can distinguish APEC from commensal strains by detecting virulence genes such as iss, iroN, ompT, hlyF, and fimC.

What samples should I submit for laboratory diagnosis of colibacillosis?

Submit liver, spleen, air sac swabs, and pericardial sac swabs from freshly dead or euthanized birds with typical lesions. Include heart blood for culture in septicemic cases. Transport samples in sterile containers with appropriate transport media. Submit at least three affected birds per flock for comprehensive testing. Avoid birds that have received antimicrobial therapy within 48 hours.

How long should antimicrobial treatment continue for colibacillosis?

Treatment duration depends on the antimicrobial used and clinical response. Most courses range from 3 to 5 days. Monitor mortality and clinical signs daily. If no improvement occurs within 48 hours, reassess the diagnosis and susceptibility results. Complete the full course as prescribed to prevent relapse and resistance development. Consult your veterinarian for specific treatment protocols.

Can colibacillosis be prevented through vaccination?

Vaccination can reduce the incidence and severity of colibacillosis. Autogenous vaccines made from farm-specific isolates provide serotype-matched protection. Commercial vaccines are available in some regions. Vaccination of parent flocks provides maternal antibody transfer to progeny. Discuss vaccine options with your veterinarian based on your farm's specific serotype profile. Vaccination works best when combined with good management and biosecurity.

What management factors predispose broilers to colibacillosis?

High ammonia levels, poor ventilation, wet litter, high stocking density, and temperature stress all increase susceptibility. Respiratory viral infections damage the respiratory epithelium and allow secondary E. coli invasion. Mycoplasma infections also predispose birds to colibacillosis. Controlling these predisposing factors is essential for prevention. Water quality and line sanitation are often overlooked but important factors.

Is colibacillosis a food safety concern for consumers?

APEC strains can carry antimicrobial resistance genes that may transfer to human pathogens. Proper cooking of poultry meat to an internal temperature of 74 degrees Celsius kills E. coli bacteria. Observing antimicrobial withdrawal periods prevents drug residues in meat. Good hygiene practices during processing reduce contamination risk. The detection of mcr-1 colistin resistance in retail meat highlights the importance of antimicrobial stewardship.

When should I consider antimicrobial susceptibility testing?

Susceptibility testing should be performed for every colibacillosis outbreak to guide treatment selection. It is especially important when treatment failure occurs, when resistance is suspected, or when establishing a farm-specific antibiogram. Regional resistance patterns change over time, so regular testing is necessary for effective antimicrobial stewardship. Submit isolates from at least three affected birds per outbreak for testing.

Related Veterinary Guides

• Swarm Prevention And Management
• Broiler Litter Management
• Poultry Mortality Investigation And Flock Records
• Broiler Chicken Farming Flock Management From Placement To Processing
• Broiler Breeder Flock Management And Fertility Records

References and Further Reading

• World Organisation for Animal Health
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Dynamics of CMY-2 producing E. coli in a broiler parent flock.. Veterinary microbiology, 2017.
• High sequence similarity between avian pathogenic E. coli isolates from individual birds and within broiler chicken flocks during colibacillosis outbreaks.. Veterinary microbiology, 2022.
• First report on the molecular characteristics of mcr-1 colistin resistant E. coli isolated from retail broiler meat in Bangladesh.. International journal of food microbiology, 2023.
• Impact of dietary supplementation with Echinacea purpurea on growth performance, immunological, biochemical, and pathological findings in broiler chickens infected by pathogenic E. coli.. Tropical animal health and production, 2020.
• Prevalence and antimicrobial resistance of Salmonella and pathogenic E. coli in broiler farms, Wakiso district, Uganda.. PloS one, 2025.
• Histopathological Diagnosis and Detection of Avian Pathogenic Escherichia Coli Virulence Genes in Broiler Chickens in Indonesia.. Archives of Razi Institute, 2025.
• Characteristics, pathogenic mechanism, zoonotic potential, drug resistance, and prevention of avian pathogenic Escherichia coli (APEC). Frontiers in Microbiology, 2022.
• Andrographolide interferes quorum sensing to reduce cell damage caused by avian pathogenic Escherichia coli. Veterinary Microbiology, 2014.
• The Transcription Regulator YgeK Affects Biofilm Formation and Environmental Stress Resistance in Avian Pathogenic Escherichia coli. Animals, 2022.
• Inhibitory effects of α-cyperone on adherence and invasion of avian pathogenic Escherichia coli O78 to chicken type II pneumocytes. Veterinary Immunology and Immunopathology, 2014.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.